TABLE 1.
Cell linea | Temp (°C) | Addition(s)b | Incorporation of [3H]adenine into DNA (103 dpm/106 cells)c
|
|
---|---|---|---|---|
Mock infected | C. trachomatis infected | |||
CHO K1 | 33 | 2.1 ± 0.8 | 163 ± 11.9 | |
CHO K1 | 40 | 1.8 ± 1.0 | 111 ± 10.4 | |
CHO 58 | 33 | 1.9 ± 0.6 | 153 ± 9.4 | |
CHO 58 | 40 | 0.9 ± 0.5 | 102 ± 9.8 | |
Mouse L | 37 | 2.8 ± 1.1 | 147 ± 13.6 | |
Mouse L | 37 | Fumonisin B1 | 3.1 ± 1.3 | 154 ± 14.9 |
Mouse L | 37 | Brefeldin A | 2.4 ± 0.9 | 139 ± 9.4 |
Mouse L | 37 | Sphingomyelinase | 2.9 ± 1.3 | 144 ± 11.5 |
Mouse L | 37 | Brefeldin A + sphingomyelinase | 3.3 ± 1.6 | 137 ± 12.3 |
Triplicate cultures of wild-type CHO K1, CDP-choline synthetase mutant CHO 58, and wild-type mouse L 929 cells were seeded, cultured, and infected with C. trachomatis L2 or left as mock-infected controls as described in Materials and Methods and the report of McClarty and Tipples (25).
For mock-infected and C. trachomatis-infected cultures treated with brefeldin A (5 μg ml−1), fumonisin B1 (20 μM), and/or sphingomyelinase (0.05 U ml−1), the inhibitors were added at the start of the infection (2 h p.i.).
Incorporation of radiolabelled adenine into host cell or C. trachomatis L2 DNA was determined after addition of radiolabel at 22 h p.i. and continuing incubation for 3 h. Cells were harvested and processed as described previously (25). Results are expressed as means ± standard deviations of results from three separate experiments.